Figure 6.

Statin use improves outcomes of radiotherapy in HNSCC patients. Analysis was conducted using data from 518 medical records of stage III‐IVB HNSCC patients, a fraction of whom were incidentally being treated with statins concomitantly with their radiotherapy. Time to local control or distant control was determined from last date of radiotherapy. Survival curves were plotted using the Kaplan–Meier method, and significance was assessed using the Log Rank test. Data indicate that incidental use of statins was statistically associated with better local, but not distant, control in HNSCC patients.